The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10750 malaria professionals are enjoying the free benefits of MalariaWorld today

MB

Not Open Access | Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M(pro), using molecular docking and dynamics simulation studies

January 7, 2021 - 10:07 -- NOT Open Access
Author(s): 
Ahamad S, Kanipakam H, Birla S, Ali MS, Gupta D
Reference: 
Eur J Pharmacol. 2021 Jan 5;890:173664

Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Main protease (Mpro) is one of the vital drug targets amongst all the coronaviruses, as the protein is indispensable for virus replication. The study aimed to identify promising lead molecules against Mpro enzyme through virtual screening of Malaria Venture (MMV) Malaria Box (MB) comprising of 400 experimentally proven compounds.

Subscribe to RSS - MB